CLINICAL_TRIALS
trial_result
· 2023-02-23
Clinical Trial Update: Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy [Phase 2]
Summary
Phase 2 clinical trial update on hyperpolarized xenon gas MRI imaging for radiotherapy planning/assessment in non-small cell lung cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Oxford University Hospitals NHS Trust | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-02-23